Oxipit.ai

At the annual RSNA meeting, the AI medical imaging company will present the new ChestEye Quality AI double reading tool.

AI medical imaging company Oxipit appointed Dany Chammas as their new Chief Commercial Officer.

The AI medical imaging company will showcase the first autonomous AI diagnostics application for healthy patient report automation.

With recent partnerships in Nigeria and strong foothold in Latin America, the new agreement is an important step towards creating a global, locally present network of Oxipit software distributors.

Teleradiologia de Colombia – a leading diagnostic imaging services provider in Latin America – is rolling out Oxipit AI solutions across its network.

The innovation allows efficient use of high-resolution chest X-ray images for machine learning model training and is especially relevant for improving lung nodule detection.

The AI medical imaging company has received an Australian Register of Therapeutic Goods Class IIa medical device certificate for ChestEye AI imaging service.

The AI medical imaging company will showcase ChestEye Negative service at Arab Health conference in Dubai. ChestEye Negative produces preliminary reports for chest X-rays with no abnormality.

The AI medical imaging company will offer a first public preview of Dynamics feature for its award winning ChestEye CAD suite.

A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics (CARING) found that nearly 80% of AI generated chest X-ray case reports were as accurate as produced by a radiology specialist.